ID   HCAR2_HUMAN             Reviewed;         363 AA.
AC   Q8TDS4; A0PJL5; A7LGG3;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   07-APR-2021, entry version 144.
DE   RecName: Full=Hydroxycarboxylic acid receptor 2;
DE   AltName: Full=G-protein coupled receptor 109A;
DE   AltName: Full=G-protein coupled receptor HM74A;
DE   AltName: Full=Niacin receptor 1;
DE   AltName: Full=Nicotinic acid receptor;
GN   Name=HCAR2; Synonyms=GPR109A, HCA2, HM74A, NIACR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND CHARACTERIZATION.
RX   PubMed=12522134; DOI=10.1074/jbc.m210695200;
RA   Wise A., Foord S.M., Fraser N.J., Barnes A.A., Elshourbagy N., Eilert M.,
RA   Ignar D.M., Murdock P.R., Steplewski K., Green A., Brown A.J., Dowell S.J.,
RA   Szekeres P.G., Hassall D.G., Marshall F.H., Wilson S., Pike N.B.;
RT   "Molecular identification of high and low affinity receptors for nicotinic
RT   acid.";
RL   J. Biol. Chem. 278:9869-9874(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12044878; DOI=10.1016/s0014-5793(02)02775-8;
RA   Takeda S., Kadowaki S., Haga T., Takaesu H., Mitaku S.;
RT   "Identification of G protein-coupled receptor genes from the human genome
RT   sequence.";
RL   FEBS Lett. 520:97-101(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S.,
RA   Tsutsumi S., Aburatani H., Asai K., Akiyama Y.;
RT   "Genome-wide discovery and analysis of human seven transmembrane helix
RT   receptor genes.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-311 AND ILE-317.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=17932499; DOI=10.1038/sj.cdd.4402238;
RA   Kostylina G., Simon D., Fey M.F., Yousefi S., Simon H.U.;
RT   "Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A).";
RL   Cell Death Differ. 15:134-142(2008).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=21454438; DOI=10.1124/pr.110.003301;
RA   Offermanns S., Colletti S.L., Lovenberg T.W., Semple G., Wise A.,
RA   Ijzerman A.P.;
RT   "International union of basic and clinical pharmacology. LXXXII:
RT   nomenclature and classification of hydroxy-carboxylic acid receptors
RT   (GPR81, GPR109A, and GPR109B).";
RL   Pharmacol. Rev. 63:269-290(2011).
CC   -!- FUNCTION: Acts as a high affinity receptor for both nicotinic acid
CC       (also known as niacin) and (D)-beta-hydroxybutyrate and mediates
CC       increased adiponectin secretion and decreased lipolysis through G(i)-
CC       protein-mediated inhibition of adenylyl cyclase. This pharmacological
CC       effect requires nicotinic acid doses that are much higher than those
CC       provided by a normal diet. Mediates nicotinic acid-induced apoptosis in
CC       mature neutrophils. Receptor activation by nicotinic acid results in
CC       reduced cAMP levels which may affect activity of cAMP-dependent protein
CC       kinase A and phosphorylation of target proteins, leading to neutrophil
CC       apoptosis. The rank order of potency for the displacement of nicotinic
CC       acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic
CC       acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid
CC       = nicotinamide. {ECO:0000269|PubMed:17932499}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17932499};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:17932499}.
CC   -!- TISSUE SPECIFICITY: Expression largely restricted to adipose tissue and
CC       spleen. Expressed on mature neutrophils but not on immature neutrophils
CC       or eosinophils. {ECO:0000269|PubMed:12522134,
CC       ECO:0000269|PubMed:17932499}.
CC   -!- DEVELOPMENTAL STAGE: Expression in neutrophils occurs in the late
CC       terminal differentiation phase. {ECO:0000269|PubMed:17932499}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/gpr109a/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY148884; AAN71621.1; -; mRNA.
DR   EMBL; AB083632; BAB89345.1; -; Genomic_DNA.
DR   EMBL; AB065876; BAC06094.1; -; Genomic_DNA.
DR   EMBL; EU012026; ABS29270.1; -; Genomic_DNA.
DR   EMBL; BC027965; AAH27965.1; -; mRNA.
DR   EMBL; BC056419; AAH56419.1; -; mRNA.
DR   CCDS; CCDS9235.1; -.
DR   RefSeq; NP_808219.1; NM_177551.3.
DR   SMR; Q8TDS4; -.
DR   STRING; 9606.ENSP00000375066; -.
DR   BindingDB; Q8TDS4; -.
DR   ChEMBL; CHEMBL3785; -.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB08949; Inositol nicotinate.
DR   DrugBank; DB00627; Niacin.
DR   DrugCentral; Q8TDS4; -.
DR   GuidetoPHARMACOLOGY; 312; -.
DR   iPTMnet; Q8TDS4; -.
DR   PhosphoSitePlus; Q8TDS4; -.
DR   BioMuta; HCAR2; -.
DR   DMDM; 74762622; -.
DR   EPD; Q8TDS4; -.
DR   jPOST; Q8TDS4; -.
DR   MassIVE; Q8TDS4; -.
DR   MaxQB; Q8TDS4; -.
DR   PaxDb; Q8TDS4; -.
DR   PeptideAtlas; Q8TDS4; -.
DR   PRIDE; Q8TDS4; -.
DR   ProteomicsDB; 74335; -.
DR   Antibodypedia; 19187; 200 antibodies.
DR   DNASU; 338442; -.
DR   Ensembl; ENST00000328880; ENSP00000375066; ENSG00000182782.
DR   GeneID; 338442; -.
DR   KEGG; hsa:338442; -.
DR   UCSC; uc001ucx.2; human.
DR   CTD; 338442; -.
DR   DisGeNET; 338442; -.
DR   GeneCards; HCAR2; -.
DR   HGNC; HGNC:24827; HCAR2.
DR   HPA; ENSG00000182782; Tissue enhanced (blood).
DR   MIM; 609163; gene.
DR   neXtProt; NX_Q8TDS4; -.
DR   OpenTargets; ENSG00000182782; -.
DR   PharmGKB; PA165961843; -.
DR   VEuPathDB; HostDB:ENSG00000182782.7; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00990000203619; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q8TDS4; -.
DR   OMA; MNWHHPQ; -.
DR   OrthoDB; 903658at2759; -.
DR   TreeFam; TF330775; -.
DR   PathwayCommons; Q8TDS4; -.
DR   Reactome; R-HSA-3296197; Hydroxycarboxylic acid-binding receptors.
DR   Reactome; R-HSA-373076; Class A/1 (Rhodopsin-like receptors).
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   BioGRID-ORCS; 338442; 5 hits in 976 CRISPR screens.
DR   GenomeRNAi; 338442; -.
DR   Pharos; Q8TDS4; Tclin.
DR   PRO; PR:Q8TDS4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8TDS4; protein.
DR   Bgee; ENSG00000182782; Expressed in blood and 92 other tissues.
DR   ExpressionAtlas; Q8TDS4; baseline and differential.
DR   Genevisible; Q8TDS4; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070553; F:nicotinic acid receptor activity; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0001781; P:neutrophil apoptotic process; IDA:UniProtKB.
DR   GO; GO:0070165; P:positive regulation of adiponectin secretion; ISS:UniProtKB.
DR   GO; GO:0033031; P:positive regulation of neutrophil apoptotic process; IDA:UniProtKB.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR028017; HCAR2/3_rcpt.
DR   PANTHER; PTHR46048:SF5; PTHR46048:SF5; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..363
FT                   /note="Hydroxycarboxylic acid receptor 2"
FT                   /id="PRO_0000069603"
FT   TOPO_DOM        1..33
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        34..54
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..63
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        64..84
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        85..102
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..142
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        164..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..213
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        214..229
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..250
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        251..273
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        274..294
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        295..363
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EP66"
FT   DISULFID        100..177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         187
FT                   /note="Q -> R (in dbSNP:rs676770)"
FT                   /id="VAR_049400"
FT   VARIANT         198
FT                   /note="F -> L (in dbSNP:rs676823)"
FT                   /id="VAR_049401"
FT   VARIANT         311
FT                   /note="R -> C (in dbSNP:rs7314976)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_038713"
FT   VARIANT         317
FT                   /note="M -> I (in dbSNP:rs2454727)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_038714"
SQ   SEQUENCE   363 AA;  41850 MW;  C4B0EEC9CCB81D56 CRC64;
     MNRHHLQDHF LEIDKKNCCV FRDDFIVKVL PPVLGLEFIF GLLGNGLALW IFCFHLKSWK
     SSRIFLFNLA VADFLLIICL PFLMDNYVRR WDWKFGDIPC RLMLFMLAMN RQGSIIFLTV
     VAVDRYFRVV HPHHALNKIS NRTAAIISCL LWGITIGLTV HLLKKKMPIQ NGGANLCSSF
     SICHTFQWHE AMFLLEFFLP LGIILFCSAR IIWSLRQRQM DRHAKIKRAI TFIMVVAIVF
     VICFLPSVVV RIRIFWLLHT SGTQNCEVYR SVDLAFFITL SFTYMNSMLD PVVYYFSSPS
     FPNFFSTLIN RCLQRKMTGE PDNNRSTSVE LTGDPNKTRG APEALMANSG EPWSPSYLGP
     TSP
//
